192 related articles for article (PubMed ID: 19727541)
1. Is (18)F-fluorodeoxyglucose positron emission tomography meaningful for estimating the efficacy of corticosteroid therapy in patients with autoimmune pancreatitis?
Shigekawa M; Yamao K; Sawaki A; Hara K; Takagi T; Bhatia V; Nishio M; Tamaki T; El-Amin H; Sayed Zel-A; Mizuno N
J Hepatobiliary Pancreat Sci; 2010 May; 17(3):269-74. PubMed ID: 19727541
[TBL] [Abstract][Full Text] [Related]
2. FDG-PET/CT findings of autoimmune pancreatitis.
Kamisawa T; Takum K; Anjiki H; Egawa N; Kurata M; Honda G; Tsuruta K
Hepatogastroenterology; 2010; 57(99-100):447-50. PubMed ID: 20698206
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of positron emission tomography in the evaluation of distribution and activity of systemic lesions associated with autoimmune pancreatitis.
Matsubayashi H; Furukawa H; Maeda A; Matsunaga K; Kanemoto H; Uesaka K; Fukutomi A; Ono H
Pancreatology; 2009; 9(5):694-9. PubMed ID: 19684434
[TBL] [Abstract][Full Text] [Related]
4.
Zhang J; Jia G; Zuo C; Jia N; Wang H
BMC Cancer; 2017 Oct; 17(1):695. PubMed ID: 29061130
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of whole-body FDG-PET or PET/CT for autoimmune pancreatitis and associated extrapancreatic autoimmune lesions.
Nakajo M; Jinnouchi S; Fukukura Y; Tanabe H; Tateno R; Nakajo M
Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2088-95. PubMed ID: 17713765
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune pancreatitis: whole-body 18F-FDG PET/CT findings.
Zhang J; Shao C; Wang J; Cheng C; Zuo C; Sun G; Cui B; Dong A; Liu Q; Kong L
Abdom Imaging; 2013 Jun; 38(3):543-9. PubMed ID: 23223832
[TBL] [Abstract][Full Text] [Related]
7. Clinical Utility of FDG PET/CT in Patients with Autoimmune Pancreatitis: a Case-Control Study.
Cheng MF; Guo YL; Yen RF; Chen YC; Ko CL; Tien YW; Liao WC; Liu CJ; Wu YW; Wang HP
Sci Rep; 2018 Feb; 8(1):3651. PubMed ID: 29483544
[TBL] [Abstract][Full Text] [Related]
8. Clinical Usefulness of [18F]-Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography/Computed Tomography for Distinguishing Between Autoimmune Pancreatitis and Pancreatic Cancer.
Ohtani M; Ofuji K; Akazawa Y; Saito Y; Nosaka T; Ozaki Y; Takahashi K; Naito T; Matsuda H; Hiramatsu K; Nakamoto Y
Pancreas; 2021 Aug; 50(7):1014-1019. PubMed ID: 34629452
[TBL] [Abstract][Full Text] [Related]
9. Role of 18F-FDG PET/CT in the management of a case of autoimmune pancreatitis with extrapancreatic manifestations.
Santhosh S; Bhattacharya A; Harisankar CN; Kochhar R; Mittal BR
Clin Nucl Med; 2013 Nov; 38(11):e423-5. PubMed ID: 23510878
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography.
Ozaki Y; Oguchi K; Hamano H; Arakura N; Muraki T; Kiyosawa K; Momose M; Kadoya M; Miyata K; Aizawa T; Kawa S
J Gastroenterol; 2008; 43(2):144-51. PubMed ID: 18306988
[TBL] [Abstract][Full Text] [Related]
11. Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study.
Moon SH; Kim MH; Park DH; Hwang CY; Park SJ; Lee SS; Seo DW; Lee SK
Gut; 2008 Dec; 57(12):1704-12. PubMed ID: 18583399
[TBL] [Abstract][Full Text] [Related]
12. FDG PET and PET/CT monitoring of autoimmune pancreatitis associated with extrapancreatic autoimmune disease.
Nakajo M; Jinnouchi S; Noguchi M; Uozumi K; Tanabe H; Tateno R; Nakajo M
Clin Nucl Med; 2007 Apr; 32(4):282-5. PubMed ID: 17413574
[TBL] [Abstract][Full Text] [Related]
13. Utility of 18F-FDG PET/CT for differentiation of autoimmune pancreatitis with atypical pancreatic imaging findings from pancreatic cancer.
Lee TY; Kim MH; Park DH; Seo DW; Lee SK; Kim JS; Lee KT
AJR Am J Roentgenol; 2009 Aug; 193(2):343-8. PubMed ID: 19620430
[TBL] [Abstract][Full Text] [Related]
14. 18F-fluorodeoxyglucose positron emission tomography features of idiopathic retroperitoneal fibrosis.
Nakajo M; Jinnouchi S; Tanabe H; Tateno R; Nakajo M
J Comput Assist Tomogr; 2007; 31(4):539-43. PubMed ID: 17882028
[TBL] [Abstract][Full Text] [Related]
15. Extrapancreatic F-18 FDG accumulation in autoimmune pancreatitis.
Sato M; Okumura T; Shioyama Y; Imura J
Ann Nucl Med; 2008 Apr; 22(3):215-9. PubMed ID: 18498037
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose for the differentiation of chronic pancreatitis and pancreatic cancer.
Imdahl A; Nitzsche E; Krautmann F; Högerle S; Boos S; Einert A; Sontheimer J; Farthmann EH
Br J Surg; 1999 Feb; 86(2):194-9. PubMed ID: 10100786
[TBL] [Abstract][Full Text] [Related]
17. The differentiation of autoimmune pancreatitis and pancreatic cancer using imaging findings.
Shin JU; Lee JK; Kim KM; Lee KH; Lee KT; Kim YK; Lim JH; Jang KT
Hepatogastroenterology; 2013; 60(125):1174-81. PubMed ID: 24298613
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune pancreatitis: CT patterns and their changes after steroid treatment.
Manfredi R; Graziani R; Cicero C; Frulloni L; Carbognin G; Mantovani W; Mucelli RP
Radiology; 2008 May; 247(2):435-43. PubMed ID: 18430876
[TBL] [Abstract][Full Text] [Related]
19. [Differentiation of autoimmune pancreatitis and pancreatic ductal adenocarcinoma based on multi-modality texture features in
Zhang Y; Cheng C; Liu Z; Pan G; Sun G; Yang X; Zuo C
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2019 Oct; 36(5):755-762. PubMed ID: 31631623
[TBL] [Abstract][Full Text] [Related]
20. Focal autoimmune pancreatitis: radiological characteristics help to distinguish from pancreatic cancer.
Sun GF; Zuo CJ; Shao CW; Wang JH; Zhang J
World J Gastroenterol; 2013 Jun; 19(23):3634-41. PubMed ID: 23801866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
